Abstract
Loss of lean mass is a potential concern for semaglutide-induced weight loss. This study indicates that semaglutide has unexpected effects on skeletal muscle mass and strength in mice, demonstrating a need to more carefully assess these effects in humans.
Copyright © 2025 Elsevier Inc. All rights reserved.
MeSH terms
-
Animals
-
Glucagon-Like Peptide 1
-
Glucagon-Like Peptides* / pharmacology
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Muscle Strength* / drug effects
-
Muscle, Skeletal* / drug effects
-
Muscle, Skeletal* / metabolism
-
Muscle, Skeletal* / physiology
-
Semaglutide
-
Weight Loss / drug effects
Substances
-
Glucagon-Like Peptides
-
Glucagon-Like Peptide 1
-
Semaglutide